BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,090 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $24,426,000 | +29.5% | 303,433 | +35.7% | 0.03% | +17.4% |
| Q1 2021 | $18,861,000 | -5.0% | 223,635 | -9.6% | 0.02% | -11.5% |
| Q4 2020 | $19,846,000 | -8.1% | 247,335 | -7.9% | 0.03% | -23.5% |
| Q3 2020 | $21,586,000 | -18.8% | 268,414 | -13.0% | 0.03% | -26.1% |
| Q2 2020 | $26,579,000 | +9.0% | 308,695 | +2.8% | 0.05% | -11.5% |
| Q1 2020 | $24,389,000 | +2.8% | 300,391 | +5.9% | 0.05% | +23.8% |
| Q4 2019 | $23,727,000 | -52.5% | 283,749 | -50.3% | 0.04% | -20.8% |
| Q3 2019 | $49,928,000 | +115.1% | 570,806 | +101.4% | 0.05% | +6.0% |
| Q2 2019 | $23,209,000 | -1.2% | 283,379 | -2.0% | 0.05% | -3.8% |
| Q1 2019 | $23,500,000 | +23.9% | 289,021 | +0.3% | 0.05% | +8.3% |
| Q4 2018 | $18,971,000 | -19.0% | 288,221 | -5.1% | 0.05% | -2.0% |
| Q3 2018 | $23,418,000 | -1.2% | 303,778 | -5.3% | 0.05% | -14.0% |
| Q2 2018 | $23,699,000 | +16.8% | 320,945 | +2.9% | 0.06% | +14.0% |
| Q1 2018 | $20,282,000 | -30.7% | 311,845 | -31.1% | 0.05% | -33.3% |
| Q4 2017 | $29,253,000 | +5.8% | 452,545 | +2.7% | 0.08% | -3.8% |
| Q3 2017 | $27,649,000 | +15.0% | 440,621 | +8.7% | 0.08% | +5.4% |
| Q2 2017 | $24,045,000 | +11.9% | 405,412 | -2.1% | 0.07% | +5.7% |
| Q1 2017 | $21,486,000 | +67.4% | 414,312 | +43.1% | 0.07% | +45.8% |
| Q4 2016 | $12,837,000 | -10.5% | 289,512 | -3.9% | 0.05% | -11.1% |
| Q3 2016 | $14,338,000 | -6.7% | 301,212 | -15.4% | 0.05% | -10.0% |
| Q2 2016 | $15,361,000 | +7.6% | 355,912 | -1.5% | 0.06% | -4.8% |
| Q1 2016 | $14,279,000 | +5.1% | 361,412 | +1.5% | 0.06% | +8.6% |
| Q4 2015 | $13,586,000 | +23.1% | 356,112 | +6.0% | 0.06% | +18.4% |
| Q3 2015 | $11,041,000 | -41.4% | 336,112 | -28.5% | 0.05% | -36.4% |
| Q2 2015 | $18,850,000 | -35.3% | 470,312 | +11.0% | 0.08% | -36.4% |
| Q1 2015 | $29,119,000 | +0.7% | 423,612 | +7.4% | 0.12% | -6.2% |
| Q4 2014 | $28,914,000 | +16.8% | 394,512 | +14.4% | 0.13% | +8.4% |
| Q3 2014 | $24,753,000 | -3.8% | 344,892 | -3.1% | 0.12% | -3.3% |
| Q2 2014 | $25,731,000 | +1.1% | 355,892 | +2.9% | 0.12% | -3.1% |
| Q1 2014 | $25,450,000 | +3.8% | 345,892 | -1.9% | 0.13% | +0.8% |
| Q4 2013 | $24,530,000 | +7.1% | 352,692 | +1.2% | 0.13% | -1.6% |
| Q3 2013 | $22,899,000 | -2.6% | 348,592 | +2.7% | 0.13% | -4.5% |
| Q2 2013 | $23,503,000 | – | 339,292 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |